BIOMUNE SYSTEMS INC
8-K, EX-10, 2000-08-15
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: BIOMUNE SYSTEMS INC, 8-K, EX-10, 2000-08-15
Next: BIOMUNE SYSTEMS INC, 8-K, EX-10, 2000-08-15



                                 PROMISSORY NOTE

$1,115,024.80                                                     August 7, 2000

         FOR VALUE RECEIVED,  the undersigned,  Donlar Corporation,  an Illinois
corporation  ("Donlar"),  hereby  promises pay to the order of Biomune  Systems,
Inc.,  a  Nevada   corporation   (together  with  its  successors  and  assigns,
"Biomune"), at its office at 64 East Winchester, Suite 303, Salt Lake City, Utah
84107, or at such other place as the holder hereof may designate in writing,  in
lawful money of the United  States of America,  the principal sum of One Million
One Hundred Fifteen Thousand Twenty-four Dollars and 80/100 ($1,115,024.80),  or
such lesser principal sum as may then be owed by Donlar to Biomune hereunder, on
or before December 31, 2000.

         This  Promissory  Note (this "Note") shall bear simple  interest on the
unpaid  principal  amount  hereof  from time to time  outstanding  from the date
hereof until  December 31, 2000,  at a rate of ten percent  (10%) (the  "Rate").
Accrued  interest on this Note shall be due and payable at maturity and shall be
made by Donlar to Biomune at the address listed above.  Interest  payments shall
be computed using the Rate shall and based on the outstanding  principal balance
of this Note,  together with any remaining  accrued  interest,  costs,  fees and
expenses thereon. Upon maturity,  the outstanding principal balance of this Note
shall be  immediately  due and  payable,  together  with any  remaining  accrued
interest, costs, fees and expenses thereon.

         This Note may be prepaid by Donlar without penalty at any time.

         Donlar  hereby  waives  presentment  for  payment,  demand,  notice  of
nonpayment,  notice of dishonor, protest of any dishonor, notice of protest, and
protest of this Note and all other  notices  in  connection  with the  delivery,
acceptance,  performance,  default,  or enforcement of the payment of this Note,
and agrees  that its  liability  shall be  unconditional  without  regard to the
liability  of any other  party or person and shall not in any manner be affected
by any indulgence, extension of time, renewal, waiver or modification granted or
consented to by the holder  hereof;  and Donlar agrees that  additional  makers,
endorsers,  guarantors,  or sureties may become parties hereto without notice to
Donlar or affecting Donlar's liability hereunder.

         It is the  intention  of the  parties  hereto to  conform  strictly  to
applicable  usury  laws as in effect  from time to time  during the term of this
Note.  Accordingly,  if any  transaction  contemplated  hereby would be usurious
under applicable law (including the laws of the United States of America,  or of
any other jurisdiction whose laws may be mandatorily applicable),  then, in that
event,  notwithstanding anything to the contrary in this Note, it is agreed that
the aggregate of all  consideration  that constitutes  interest under applicable
law that is contracted for,  charged or received under this Note or otherwise in
connection with this Note shall under no circumstances exceed the maximum amount
of interest allowed by applicable law, any excess shall be credited to Donlar by
Biomune  (or if such  consideration  shall have been paid in full,  such  excess
refunded to Donlar by Biomune).

         The holder  hereof  shall not by any act of omission or  commission  be
deemed to waive any of its rights or remedies hereunder unless such waiver be in
writing  and  signed  by  the  holder  hereof  (and  then  only  to  the  extent
specifically  set  forth  therein).  A  waiver  of any one  event  shall  not be
construed  as  continuing  or as a bar to or waiver of such right or remedy on a
subsequent event.

                                        1


<PAGE>


         Whenever possible,  each provision of this Note shall be interpreted in
such  manner as to be  effective  and valid  under  applicable  law,  but if any
provision  of this Note  shall be  prohibited  or invalid  under such law,  such
provision  shall  be  ineffective  only to the  extent  of such  prohibition  or
invalidity, without invalidating the remainder of such provisions of this Note.

         This  Note  shall  not be  amended,  supplemented  or  modified  except
pursuant to a writing signed by both Donlar and Biomune.

         This Note shall inure to the benefit of Biomune and its  successors and
assigns  and shall be binding  upon  Donlar  and its  successors  and  permitted
assigns.  As used  herein,  the term the  "Biomune"  shall mean and  include the
successors and assigns of the identified payee and the holder or holders of this
Note from time to time.

         This Note shall be  construed,  governed,  interpreted  and enforced in
accordance with the laws of the State of Nevada,  without regard to conflicts of
law principles.

         IN WITNESS  WHEREOF,  Donlar has caused this Promissory Note to be duly
executed  and  delivered  by its  authorized  officer as of the date first above
written.

                                        DONLAR CORPORATION


                                        By:
                                        Name:
                                        Title:

                                        2







© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission